Kristen Harrington-Smith - 15 Feb 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Kristen Harrington-Smith
Issuer symbol
EFTR on OTC
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 17:26:51 UTC
Previous filing
17 Nov 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 15 Feb 2022 Common Stock 40,000 $4.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on February 15, 2022, subject to the Reporting Person's continued service with the Issuer through each vesting date.